Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway.
Xu M, Xu C, Qiu Y, Feng Y, Shi Q, Liu Y, Deng H, Ma X, Lin N, Shi Q, Shen Z, Meng S, Yang J, Chen H, Xue F.
Xu M, et al. Among authors: deng h.
J Nanobiotechnology. 2024 Dec 19;22(1):782. doi: 10.1186/s12951-024-02999-z.
J Nanobiotechnology. 2024.
PMID: 39702231
Free PMC article.